Bristol-Myers: gets offer for French consumer health unit
(CercleFinance.com) - Bristol-Myers Squibb has received an offer for its French consumer health business UPSA, as the company proceeds with efforts to further refine its portfolio to focus on serious diseases.
Japan's Taisho has offered to buy UPSA, famous for its aspirins and vitamins, for 1.6 billion dollars, the US drugmaker said on Wednesday.
Taisho is the largest over-the-counter (OTC) drug company in Japan, with over a century of experience in this field. It owns anti-inflammatory analgesic, cold and flu and hair growth drugs in Japan and Southeast Asia.
The transaction, if it materialises, is expected to be completed in the first half of 2019, Bristol-Myers said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
Japan's Taisho has offered to buy UPSA, famous for its aspirins and vitamins, for 1.6 billion dollars, the US drugmaker said on Wednesday.
Taisho is the largest over-the-counter (OTC) drug company in Japan, with over a century of experience in this field. It owns anti-inflammatory analgesic, cold and flu and hair growth drugs in Japan and Southeast Asia.
The transaction, if it materialises, is expected to be completed in the first half of 2019, Bristol-Myers said.
Copyright (c) 2018 CercleFinance.com. All rights reserved.